Martin Biotech

GPTKB entity

Statements (44)
Predicate Object
gptkbp:instanceOf biotechnology company
gptkbp:acquisition gptkb:BioGen_Solutions
gptkbp:awardedBy Best_Biotech_Company_2021
gptkbp:employs over 500 people
gptkbp:founded 2000
gptkbp:founder gptkb:Dr._Martin_Smith
gptkbp:hasAwards Innovative Research Award 2022
Sustainability Award 2023
gptkbp:hasClient gptkb:NutriBio
PharmaCorp
EcoFarms
AgriTech_Innovations
MedHealth_Solutions
gptkbp:hasCollaborationsWith gptkb:Stanford_University
gptkb:University_of_California
gptkbp:hasEvents Community Outreach Program
Research Symposium 2023
Annual Biotech Conference
Product Launch 2021
Investor Day 2022
gptkbp:hasFilm to be a leader in innovative biotech solutions.
gptkbp:hasMission to advance biotechnology for health and sustainability
gptkbp:hasPart research and development department
production facility
gptkbp:hasProductLine GeneX
CellEnhancer
VaccinePro
gptkbp:hasResearchInterest $10 million from NIH
$5 million from EU
gptkbp:hasResidence $200 million
gptkbp:hasSocialMedia @MartinBiotech_on_Twitter
Martin_Biotech_on_Facebook
Martin_Biotech_on_LinkedIn
gptkbp:hasTechnology CRISPR
synthetic biology
biomanufacturing
gptkbp:hasWebsite www.martinbiotech.com
gptkbp:headquarters gptkb:San_Francisco,_California
https://www.w3.org/2000/01/rdf-schema#label Martin Biotech
gptkbp:operatesIn gptkb:Asia
gptkb:North_America
Europe
gptkbp:partnerships gptkb:HealthCorp
gptkbp:specializesIn genetic engineering